NEW YORK (GenomeWeb News) — Warnex today said Novartis has hired it to perform bioanalytical and pharmacogenetic services for the drug maker’s leukemia and intestinal tumors program.

Warnex said its Bioanalytical Services division will use its liquid chromatography and mass spec technologies to test blood levels of Novartis’ drug Gleevec to “help identify non-adherence or suboptimal dosing.”

Warnex also will perform PCR-based diagnostic tests to determine if patients have chromosomal abnormalities.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.